Literature DB >> 5904178

Catecholamine-producing neural tumors other than pheochromocytoma.

H Käser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5904178

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  9 in total

1.  Intramedullary secretory gangliocytoma.

Authors:  B Azzarelli; T G Luerssen; T M Wolfe
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Secretory characteristics of phaeochromocytoma and related tumours. Their diagnostic and clinical significance.

Authors:  G Walters
Journal:  Ann R Coll Surg Engl       Date:  1969-09       Impact factor: 1.891

3.  [Proceedings: Clinical symptomatology and differential diagnosis of retroperitoneal tumors (author's transl)].

Authors:  H Remé
Journal:  Langenbecks Arch Chir       Date:  1973

4.  [Neurosurgical findings in different types of sympathetic neuroblastomas].

Authors:  G Orf
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1972

5.  Combined therapy of neuroblastoma.

Authors:  C W Van Way; R B Carlisle; S E Stephenson
Journal:  Ann Surg       Date:  1968-06       Impact factor: 12.969

6.  [Vasoactive endogenous substances and pharmacological agents with peripheral action].

Authors:  E Muscholl
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1967

7.  The management of the patient with catecholamine excess.

Authors:  M H Wheeler; M J Chare; T R Austin; J H Lazarus
Journal:  World J Surg       Date:  1982-11       Impact factor: 3.352

8.  The value of determination of homovanillic and vanillylmandelic acids in plasma for the diagnosis and follow-up of neuroblastoma in children.

Authors:  M Gahr; D H Hunneman
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

9.  Biogenic amines in cultured neuroblastoma and astrocytoma cells.

Authors:  R Narotzky; W Bondareff
Journal:  J Cell Biol       Date:  1974-10       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.